Press Releases
GeoVax and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 Vaccine Development
GeoVax Labs, Inc., a biotechnology company developing human vaccines and immunotherapies against infectious diseases and cancer, announced that Beijing- and Philadelphia-based Sino Biological, Inc....
Press Releases
Quotient Limited Announces CE Mark for its SARS-CoV-2 Antibody Microarray
Quotient Limited, a commercial-stage diagnostics company, headquartered in Eysins, Switzerland, announced that it has completed the process for declaring conformity to the essential requirements...
Press Releases
Notable and MDS Foundation Partner on MDS Trials and New Drug Therapies
California-based Notable announced that it has entered a partnership with the MDS Foundation, which is dedicated to providing insight to families on future clinical...
News
Massachusetts Hospital to Assess Mallinckrodt’s Nitric Oxide Treatment for COVID-19
Mallinckrodt and Massachusetts General Hospital teamed up to evaluate the potential benefits of inhaled nitric oxide as a treatment for pulmonary complications in patients...
Press Releases
Geneius Develops Off-the-Shelf T Cell Therapy Targeting SARS-CoV-2
Geneius Biotechnology is developing T cells as a quasi-personalized, off-the-shelf, therapy and preventive measure against COVID-19. The assumption is that by increasing the number...
Drug Research
Trio pharmaceuticals and ajinomoto bio pharma services enter into a development collaboration for a novel antibody therapeutic
Trio Pharmaceuticals, Inc., a cancer therapeutics company developing novel dual action antibody drugs, and Ajinomoto Bio-Pharma Services, have entered a development collaboration to evaluate...
Press Releases
Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Moderna’s Vaccine Against Novel Coronavirus
Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read